Guidelines: Intitut National du Cancer Guidelines (Luxembourg): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forproviders}} | {{forproviders}} {{forpolicymakers}} | ||
Go back to [[Luxembourg]] page | Go back to [[Luxembourg]] page | ||
'''Primary purpose:''' To provide recommendations for the treatment of various types of cancers. | |||
'''Sponsor, manager or home institution:''' Intitut National du Cancer; Conseil Scientifique Domaine de la Santé. | '''Sponsor, manager or home institution:''' Intitut National du Cancer; Conseil Scientifique Domaine de la Santé. | ||
''' | '''Type of information:''' Recommendations, treatments, supportive care and follow up of colorectal cancer, gynecological cancer, breast cancer, pancreatic cancer, cutaneous malignant melanomas, hematological cancers, brain and central nervous system cancer. | ||
''' | '''Cancer areas of interest:''' | ||
'''Access to information:''' | '''Access to information:''' [https://institutnationalducancer.lu/fr/evenements-et-publications/#guidelines Click here to access]. | ||
Revision as of 16:18, 21 May 2024
Go back to Luxembourg page
Primary purpose: To provide recommendations for the treatment of various types of cancers.
Sponsor, manager or home institution: Intitut National du Cancer; Conseil Scientifique Domaine de la Santé.
Type of information: Recommendations, treatments, supportive care and follow up of colorectal cancer, gynecological cancer, breast cancer, pancreatic cancer, cutaneous malignant melanomas, hematological cancers, brain and central nervous system cancer.
Cancer areas of interest:
Access to information: Click here to access.
